Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Long-Term Deferred Tax (2016 - 2026)

Mimedx's Long-Term Deferred Tax history spans 7 years, with the latest figure at $24.1 million for Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax fell 12.85% to $24.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $24.1 million, a 12.85% decrease, with the full-year FY2025 number at $19.6 million, down 30.77% from a year prior.
  • Long-Term Deferred Tax hit $24.1 million in Q1 2026 for Mimedx, up from $19.6 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for MDXG hit a ceiling of $40.8 million in Q4 2023 and a floor of $19.6 million in Q4 2025.
  • Historically, Long-Term Deferred Tax has averaged $29.2 million across 4 years, with a median of $28.0 million in 2024.
  • Biggest five-year swings in Long-Term Deferred Tax: tumbled 30.77% in 2025 and later fell 12.85% in 2026.
  • Tracing MDXG's Long-Term Deferred Tax over 4 years: stood at $40.8 million in 2023, then crashed by 30.58% to $28.3 million in 2024, then tumbled by 30.77% to $19.6 million in 2025, then increased by 23.12% to $24.1 million in 2026.
  • Business Quant data shows Long-Term Deferred Tax for MDXG at $24.1 million in Q1 2026, $19.6 million in Q4 2025, and $21.6 million in Q3 2025.